Search clinical trials for: HER2
Total 2764 results
-
Dana-Farber Cancer InstitutePuma Biotechnology, Inc.; Translational Breast Cancer Research ConsortiumActive, not recruiting
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.Terminated
-
Novartis PharmaceuticalsCompletedSquamous Cell Carcinoma of Head and Neck | Esophageal Squamous Cell Carcinoma | HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma | HER2 + Breast Cancer | HER2 + Gastric CancerTaiwan, Spain, Canada, Korea, Republic of, United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingGlioblastoma | Malignant Glioma | WHO Grade III Glioma | Recurrent Glioma | Refractory GliomaUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.RecruitingLung Cancer | Bladder Cancer | Solid Tumor Cancers | Urinary Tract CancersUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingStage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
Veana TherapeuticsUniversity of WashingtonRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast Carcinoma | Refractory Breast CarcinomaUnited States
-
OncoSec Medical IncorporatedCompletedER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Not yet recruitingMetastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IV Colon Cancer AJCC v8 | Stage IV Colorectal Cancer AJCC v8 | Stage IV Rectal Cancer AJCC v8United States
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
University of ArizonaPfizerCompletedBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | Recurrent Breast Cancer | HER2 Positive Breast Carcinoma | Breast Cancer StageUnited States
-
SCRI Development Innovations, LLCSanofiCompleted
-
University of Alabama at BirminghamRecruiting
-
Pravin T.P KaumayaNot yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoma | EGFR OverexpressionUnited States
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Recruiting
-
AstraZenecaCompleted
-
Hospital do CoracaoPfizerRecruitingMetastatic Breast Cancer | Breast Cancer Stage IVBrazil
-
Texas Tech University Health Sciences Center, El...WithdrawnBreast Cancer | Metastatic Breast Cancer | HER-2 Positive Breast Cancer | ER Positive Breast Cancer
-
Yongchang ZhangRecruitingHER2 Insertion Mutation Positive Advanced NSCLCChina
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Unresectable Breast Carcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast Carcinoma | Metastatic HER2-Negative Breast Carcinoma | Unresectable HER2-Negative Breast Carcinoma | Locally Advanced HER2-Negative...United States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Syndax PharmaceuticalsTerminatedBreast Cancer | Invasive Breast Cancer | ER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
The Netherlands Cancer InstituteTesaro, Inc.TerminatedBreast CancerNetherlands
-
University of VirginiaWithdrawnBreast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
BayerOnyx Therapeutics, Inc.CompletedBreast CancerSpain, Ireland, Japan, Russian Federation, United States, Australia, Austria, Czechia, Belgium, China, Germany, Hungary, Israel, South Africa, United Kingdom, France, Greece, Puerto Rico, Italy, Canada, Poland, Sweden, Argentina
-
Bio-Thera SolutionsActive, not recruiting
-
Fondazione MichelangeloHoffmann-La RocheActive, not recruitingInvasive Breast CancerSpain, Italy, Germany, Austria
-
Sichuan Baili Pharmaceutical Co., Ltd.RecruitingHer2-positive/Low-expression Urinary and Digestive Tract TumorsChina
-
BiogenCompleted
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Peking Union Medical College HospitalNot yet recruitingBreast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive Tumor
-
Istituto Oncologico Veneto IRCCSAssociation for Translational Research in Oncology (AS.T.R.O.)CompletedEndocrine Sensitive HER2+/HR+ Breast CancerItaly
-
Shanghai Zhongshan HospitalUnknownGastric Cancer Surgical Specimens,18-80 Years Old, at Least Two Tumor Tissue Blocks
-
National Center for Tumor Diseases, HeidelbergTerminatedGastroEsophageal CancerGermany
-
Seagen Inc.RecruitingGastric Adenocarcinoma | Cholangiocarcinoma | Esophageal Adenocarcinoma | Colorectal Carcinoma | Gallbladder Carcinoma | GEJ AdenocarcinomaUnited States, Japan
-
George W. Sledge Jr.National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2 Positive Breast Carcinoma | Stage III Breast CancerUnited States
-
National Cancer Institute (NCI)Radiation Therapy Oncology GroupCompletedBladder Urothelial Carcinoma | Stage I Bladder Cancer AJCC v6 and v7 | Stage II Bladder Cancer AJCC v6 and v7 | Stage III Bladder Cancer AJCC v6 and v7United States, Canada
-
Institut CurieCompletedMetastatic Breast Cancer, HER2 Negative Primary TumorFrance
-
Peking University People's HospitalUnknownBreast NeoplasmsChina
-
Peking UniversityNot yet recruitingHER2 Positive Gastric CancerChina
-
Peregrine PharmaceuticalsWithdrawnBreast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer | Triple-Negative Breast Neoplasm | ER-Negative PR-Negative HER2-Negative Breast Neoplasms | ER-Negative PR-Negative HER2-Negative Breast Cancer
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingRecurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Rectal Adenocarcinoma | Colon Adenocarcinoma | ERBB2 Gene Amplification | Stage III Colon Cancer AJCC v7 | Stage III Rectal Cancer AJCC v7 | Stage IIIA Colon Cancer AJCC v7 | Stage IIIA Rectal Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage... and other conditionsUnited States, Puerto Rico
-
AstraZenecaAustrian Breast and Colorectal Cancer Study Group (ABCSG)RecruitingBreast Cancer, Early Breast CancerUnited States, Spain, Italy, Korea, Republic of, Belgium, Canada, Poland, Portugal, United Kingdom, France, China, Germany, Japan, Mexico, Thailand, Hungary, Australia, Austria, Brazil, Colombia, Taiwan, Malaysia, Philippines, Romania, ... and more
-
City of Hope Medical CenterActive, not recruitingBreast Cancer | Stage IV Breast CancerUnited States
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer InvasiveChina
-
European Organisation for Research and Treatment...Hoffmann-La Roche; UNICANCER; Janssen Diagnostics, LLC; SUCCESSCompletedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Circulating Tumor CellsFrance, Germany, Belgium, United Kingdom
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Recruiting
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.CompletedNon-Small Cell Lung CancerUnited States, Spain, Japan, Netherlands, France
-
The First Affiliated Hospital with Nanjing Medical...Recruiting